| 摘要 |
<p>It is intended to provide compositions and kits for treating tumor whereby the angiogenesis inhibitory activity and the antitumor activity of a sulfonamide-containing heterocyclic compound represented by the following formula (II) can be more effectively exerted. By combining with a VEGF inhibitor or an FGF inhibitor, the sulfonamide-containing heterocyclic compound can be effectively employed in treating cancer.</p> |
